Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 毒理學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56368
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor陳惠文(Huei-Wen Chen),林頌然(Sung-Jan Lin)
dc.contributor.authorYi-Lin Chinen
dc.contributor.author秦禕琳zh_TW
dc.date.accessioned2021-06-16T05:25:24Z-
dc.date.available2019-10-09
dc.date.copyright2014-10-09
dc.date.issued2014
dc.date.submitted2014-08-14
dc.identifier.citationBuerger, C., B. Richter, K. Woth, R. Salgo, B. Malisiewicz, S. Diehl, K. Hardt, S. Boehncke and W. H. Boehncke (2012). 'Interleukin-1beta interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.' J Invest Dermatol 132(9): 2206-2214.
Chandrasekar, B., S. Mummidi, R. P. Perla, S. Bysani, N. O. Dulin, F. Liu and P. C. Melby (2003). 'Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.' Biochem J 373(Pt 2): 547-558.
Driscoll, K. E. (2000). 'TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress.' Toxicol Lett 112-113: 177-183.
Kaplan, G., G. Walsh, L. S. Guido, P. Meyn, R. A. Burkhardt, R. M. Abalos, J. Barker, P. A. Frindt, T. T. Fajardo, R. Celona and et al. (1992). 'Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.' J Exp Med 175(6): 1717-1728.
Kawada, A., M. Hiruma, H. Noguchi, A. Ishibashi, K. Motoyoshi and I. Kawada (1997). 'Granulocyte and macrophage colony-stimulating factors stimulate proliferation of human keratinocytes.' Arch Dermatol Res 289(10): 600-602.
Klunker, S., A. Trautmann, M. Akdis, J. Verhagen, P. Schmid-Grendelmeier, K. Blaser and C. A. Akdis (2003). 'A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis.' J Immunol 171(2): 1078-1084.
Luther, G. A., J. Lamplot, X. Chen, R. Rames, E. R. Wagner, X. Liu, A. Parekh, E. Huang, S. H. Kim, J. Shen, R. C. Haydon, T. C. He and H. H. Luu (2013). 'IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma.' Cancer Lett 336(1): 222-230.
Raj, D., D. E. Brash and D. Grossman (2006). 'Keratinocyte apoptosis in epidermal development and disease.' J Invest Dermatol 126(2): 243-257.
Robbiani, D. F., R. A. Finch, D. Jager, W. A. Muller, A. C. Sartorelli and G. J. Randolph (2000). 'The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes.' Cell 103(5): 757-768.
Akira, S., K. Takeda and T. Kaisho (2001). 'Toll-like receptors: critical proteins linking innate and acquired immunity.' Nat Immunol 2(8): 675-680.
Berton, T. R., D. L. Mitchell, S. M. Fischer and M. F. Locniskar (1997). 'Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis.' J Invest Dermatol 109(3): 340-347.
Bonifati, C., M. Carducci, A. Mussi, L. D'Auria and F. Ameglio (1997). 'IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.' J Biol Regul Homeost Agents 11(4): 133-136.
Burns, F. J., A. N. Uddin, F. Wu, A. Nadas and T. G. Rossman (2004). 'Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study.' Environ Health Perspect 112(5): 599-603.
Cooper, K. D., C. Hammerberg, O. Baadsgaard, J. T. Elder, L. S. Chan, D. N. Sauder, J. J. Voorhees and G. Fisher (1990). 'IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.' J Immunol 144(12): 4593-4603.
Drexler, S. K., L. Bonsignore, M. Masin, A. Tardivel, R. Jackstadt, H. Hermeking, P. Schneider, O. Gross, J. Tschopp and A. S. Yazdi (2012). 'Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.' Proc Natl Acad Sci U S A 109(45): 18384-18389.
Durham, T. R. and E. T. Snow (2006). 'Metal ions and carcinogenesis.' EXS(96): 97-130.
Germolec, D. R., J. Spalding, H. S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida and M. I. Luster (1998). 'Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.' Am J Pathol 153(6): 1775-1785.
Grivennikov, S. I., F. R. Greten and M. Karin (2010). 'Immunity, inflammation, and cancer.' Cell 140(6): 883-899.
Hanahan, D. and R. A. Weinberg (2000). 'The hallmarks of cancer.' Cell 100(1): 57-70.
Isaacson, P. and D. H. Wright (1983). 'Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.' Cancer 52(8): 1410-1416.
Kitchin, K. T. and R. Conolly (2010). 'Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.' Chem Res Toxicol 23(2): 327-335.
Kligerman, A. D. and A. H. Tennant (2007). 'Insights into the carcinogenic mode of action of arsenic.' Toxicol Appl Pharmacol 222(3): 281-288.
Krelin, Y., E. Voronov, S. Dotan, M. Elkabets, E. Reich, M. Fogel, M. Huszar, Y. Iwakura, S. Segal, C. A. Dinarello and R. N. Apte (2007). 'Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.' Cancer Res 67(3): 1062-1071.
Lust, J. A., M. Q. Lacy, S. R. Zeldenrust, A. Dispenzieri, M. A. Gertz, T. E. Witzig, S. Kumar, S. R. Hayman, S. J. Russell, F. K. Buadi, S. M. Geyer, M. E. Campbell, R. A. Kyle, S. V. Rajkumar, P. R. Greipp, M. P. Kline, Y. Xiong, L. L. Moon-Tasson and K. A. Donovan (2009). 'Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.' Mayo Clin Proc 84(2): 114-122.
Qin, X. J., W. Liu, Y. N. Li, X. Sun, C. X. Hai, L. G. Hudson and K. J. Liu (2012). 'Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure.' Toxicol Sci 127(1): 120-129.
Qin, Y., S. Ekmekcioglu, P. Liu, L. M. Duncan, G. Lizee, N. Poindexter and E. A. Grimm (2011). 'Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.' Mol Cancer Res 9(11): 1537-1550.
Reed, J. R., R. P. Leon, M. K. Hall and K. L. Schwertfeger (2009). 'Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.' Breast Cancer Res 11(2): R21.
Ristow, H. J. (1987). 'A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein.' Proc Natl Acad Sci U S A 84(7): 1940-1944.
Rossman, T. G., A. N. Uddin and F. J. Burns (2004). 'Evidence that arsenite acts as a cocarcinogen in skin cancer.' Toxicol Appl Pharmacol 198(3): 394-404.
Rossman, T. G., A. N. Uddin, F. J. Burns and M. C. Bosland (2001). 'Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis.' Toxicol Appl Pharmacol 176(1): 64-71.
Sauder, D. N., B. M. Stanulis-Praeger and B. A. Gilchrest (1988). 'Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging.' Arch Dermatol Res 280(2): 71-76.
Schafer, M. and S. Werner (2008). 'Cancer as an overhealing wound: an old hypothesis revisited.' Nat Rev Mol Cell Biol 9(8): 628-638.
Schroder, K. and J. Tschopp (2010). 'The inflammasomes.' Cell 140(6): 821-832.
Shi, H., L. G. Hudson and K. J. Liu (2004). 'Oxidative stress and apoptosis in metal ion-induced carcinogenesis.' Free Radic Biol Med 37(5): 582-593.
Susse, S., C. J. Scholz, A. Burkle and L. Wiesmuller (2004). 'Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells.' Nucleic Acids Res 32(2): 669-680.
Tu, S., G. Bhagat, G. Cui, S. Takaishi, E. A. Kurt-Jones, B. Rickman, K. S. Betz, M. Penz-Oesterreicher, O. Bjorkdahl, J. G. Fox and T. C. Wang (2008). 'Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.' Cancer Cell 14(5): 408-419.
Zhou, R., A. S. Yazdi, P. Menu and J. Tschopp (2011). 'A role for mitochondria in NLRP3 inflammasome activation.' Nature 469(7329): 221-225.
Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham and N. E. Fusenig (1988). 'Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.' J Cell Biol 106(3): 761-771.
Abernathy, C. O., Y. P. Liu, D. Longfellow, H. V. Aposhian, B. Beck, B. Fowler, R. Goyer, R. Menzer, T. Rossman, C. Thompson and M. Waalkes (1999). 'Arsenic: health effects, mechanisms of actions, and research issues.' Environ Health Perspect 107(7): 593-597.
Ananthaswamy, H. N., S. M. Loughlin, P. Cox, R. L. Evans, S. E. Ullrich and M. L. Kripke (1997). 'Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens.' Nat Med 3(5): 510-514.
ATSDR (2000). 'Toxicological Profile for Arsenic TP-92/09.' Center for Disease Control,
Atlanta, Georgia.
Barchowsky, A., R. R. Roussel, L. R. Klei, P. E. James, N. Ganju, K. R. Smith and E. J. Dudek (1999). 'Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways.' Toxicol Appl Pharmacol 159(1): 65-75.
Berton, T. R., D. L. Mitchell, S. M. Fischer and M. F. Locniskar (1997). 'Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis.' J Invest Dermatol 109(3): 340-347.
Bonifati, C., M. Carducci, A. Mussi, L. D'Auria and F. Ameglio (1997). 'IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.' J Biol Regul Homeost Agents 11(4): 133-136.
Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham and N. E. Fusenig (1988). 'Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.' J Cell Biol 106(3): 761-771.
Buerger, C., B. Richter, K. Woth, R. Salgo, B. Malisiewicz, S. Diehl, K. Hardt, S. Boehncke and W. H. Boehncke (2012). 'Interleukin-1beta interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.' J Invest Dermatol 132(9): 2206-2214.
Burns, F. J., A. N. Uddin, F. Wu, A. Nadas and T. G. Rossman (2004). 'Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study.' Environ Health Perspect 112(5): 599-603.
Cadet, J., T. Douki, J. P. Pouget and J. L. Ravanat (2000). 'Singlet oxygen DNA damage products: formation and measurement.' Methods Enzymol 319: 143-153.
Campbell, C., A. G. Quinn, B. Angus, P. M. Farr and J. L. Rees (1993). 'Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation.' Cancer Res 53(12): 2697-2699.
Chandrasekar, B., S. Mummidi, R. P. Perla, S. Bysani, N. O. Dulin, F. Liu and P. C. Melby (2003). 'Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway.' Biochem J 373(Pt 2): 547-558.
Chavez, M. G., J. Hu, K. Seidel, C. Li, A. Jheon, A. Naveau, O. Horst and O. D. Klein (2014). 'Isolation and culture of dental epithelial stem cells from the adult mouse incisor.' J Vis Exp(87).
Chen, X., Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang and C. Y. Zhang (2008). 'Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.' Cell Res 18(10): 997-1006.
Clydesdale, G. J., G. W. Dandie and H. K. Muller (2001). 'Ultraviolet light induced injury: immunological and inflammatory effects.' Immunol Cell Biol 79(6): 547-568.
Cooper, K. D., C. Hammerberg, O. Baadsgaard, J. T. Elder, L. S. Chan, D. N. Sauder, J. J. Voorhees and G. Fisher (1990). 'IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta.' J Immunol 144(12): 4593-4603.
Danaee, H., H. H. Nelson, H. Liber, J. B. Little and K. T. Kelsey (2004). 'Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells.' Mutagenesis 19(2): 143-148.
De Benedetto, A., A. Kubo and L. A. Beck (2012). 'Skin barrier disruption: a requirement for allergen sensitization?' J Invest Dermatol 132(3 Pt 2): 949-963.
Drexler, S. K., L. Bonsignore, M. Masin, A. Tardivel, R. Jackstadt, H. Hermeking, P. Schneider, O. Gross, J. Tschopp and A. S. Yazdi (2012). 'Tissue-specific opposing functions of the inflammasome adaptor ASC in the regulation of epithelial skin carcinogenesis.' Proc Natl Acad Sci U S A 109(45): 18384-18389.
Driscoll, K. E. (2000). 'TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress.' Toxicol Lett 112-113: 177-183.
Durham, T. R. and E. T. Snow (2006). 'Metal ions and carcinogenesis.' EXS(96): 97-130.
Elias PM, F. K. (2006). 'Skin Barrier.' Taylor and Francis; New York, USA: 305–318.
Germolec, D. R., J. Spalding, H. S. Yu, G. S. Chen, P. P. Simeonova, M. C. Humble, A. Bruccoleri, G. A. Boorman, J. F. Foley, T. Yoshida and M. I. Luster (1998). 'Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.' Am J Pathol 153(6): 1775-1785.
Goldsmith, L. A. (1996). 'Skin effects of air pollution.' Otolaryngol Head Neck Surg 114(2): 217-219.
Grivennikov, S. I., F. R. Greten and M. Karin (2010). 'Immunity, inflammation, and cancer.' Cell 140(6): 883-899.
Hanahan, D. and R. A. Weinberg (2000). 'The hallmarks of cancer.' Cell 100(1): 57-70.
Hardman, M. J., P. Sisi, D. N. Banbury and C. Byrne (1998). 'Patterned acquisition of skin barrier function during development.' Development 125(8): 1541-1552.
Hartwig, A., U. D. Groblinghoff, D. Beyersmann, A. T. Natarajan, R. Filon and L. H. Mullenders (1997). 'Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts.' Carcinogenesis 18(2): 399-405.
Hemann, M. T., J. S. Fridman, J. T. Zilfou, E. Hernando, P. J. Paddison, C. Cordon-Cardo, G. J. Hannon and S. W. Lowe (2003). 'An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.' Nat Genet 33(3): 396-400.
Hou, Y. J., L. W. Dong, Y. X. Tan, G. Z. Yang, Y. F. Pan, Z. Li, L. Tang, M. Wang, Q. Wang and H. Y. Wang (2011). 'Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.' Lab Invest 91(8): 1146-1157.
Hughes, M. F. (2002). 'Arsenic toxicity and potential mechanisms of action.' Toxicol Lett 133(1): 1-16.
Hutchinson, J. (1887). 'Arsenic cancer.' Br. Med. J 2: 1280–1281.
IARC (2004 ). 'Some drinking-water disinfectants and contaminants, including
arsenic. Monographs on chloramine, chloral and chloral hydrate,
dichloroacetic acid, trichloroacetic acid and 3-chloro-4-(dichloromethyl)-
5-hydroxy-2(5H)-furanone.' IARC Monogr Eval Carcinog Risks Hum 84: 269–477.
Ichihashi, M., M. Ueda, A. Budiyanto, T. Bito, M. Oka, M. Fukunaga, K. Tsuru and T. Horikawa (2003). 'UV-induced skin damage.' Toxicology 189(1-2): 21-39.
Irwin, C., A. Barnes, D. Veres and K. Kaidbey (1993). 'An ultraviolet radiation action spectrum for immediate pigment darkening.' Photochem Photobiol 57(3): 504-507.
Isaacson, P. and D. H. Wright (1983). 'Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma.' Cancer 52(8): 1410-1416.
Jensen, J. M., S. Schutze, M. Forl, M. Kronke and E. Proksch (1999). 'Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.' J Clin Invest 104(12): 1761-1770.
Jhappan, C., F. P. Noonan and G. Merlino (2003). 'Ultraviolet radiation and cutaneous malignant melanoma.' Oncogene 22(20): 3099-3112.
Kaplan, G., G. Walsh, L. S. Guido, P. Meyn, R. A. Burkhardt, R. M. Abalos, J. Barker, P. A. Frindt, T. T. Fajardo, R. Celona and et al. (1992). 'Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.' J Exp Med 175(6): 1717-1728.
Kawada, A., M. Hiruma, H. Noguchi, A. Ishibashi, K. Motoyoshi and I. Kawada (1997). 'Granulocyte and macrophage colony-stimulating factors stimulate proliferation of human keratinocytes.' Arch Dermatol Res 289(10): 600-602.
Kitchin, K. T. (2001). 'Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.' Toxicol Appl Pharmacol 172(3): 249-261.
Kitchin, K. T. and R. Conolly (2010). 'Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.' Chem Res Toxicol 23(2): 327-335.
Kligerman, A. D. and A. H. Tennant (2007). 'Insights into the carcinogenic mode of action of arsenic.' Toxicol Appl Pharmacol 222(3): 281-288.
Klunker, S., A. Trautmann, M. Akdis, J. Verhagen, P. Schmid-Grendelmeier, K. Blaser and C. A. Akdis (2003). 'A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis.' J Immunol 171(2): 1078-1084.
Kock A, S. T., Kirnbauer R, Urbanski A, Perry P, Ansel and L. T. JC (1990). 'Human keratinocytes are a source for tumor necrosis factor a: evidence for synthesis and release upon
stimulation with endotoxin or ultraviolet.' light. J Exp Med endotoxin or ultraviolet light. J Exp Med
172: 1609–1614.
Komissarova, E. V. and T. G. Rossman (2010). 'Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure.' Toxicol Appl Pharmacol 243(3): 399-404.
Krelin, Y., E. Voronov, S. Dotan, M. Elkabets, E. Reich, M. Fogel, M. Huszar, Y. Iwakura, S. Segal, C. A. Dinarello and R. N. Apte (2007). 'Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors.' Cancer Res 67(3): 1062-1071.
Lee, C. H., S. B. Wu, C. H. Hong, G. S. Chen, Y. H. Wei and H. S. Yu (2013). 'Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers.' J Invest Dermatol 133(7): 1890-1900.
Luger, T. A. and T. Schwarz (1990). 'Evidence for an epidermal cytokine network.' J Invest Dermatol 95(6 Suppl): 100S-104S.
Lust, J. A., M. Q. Lacy, S. R. Zeldenrust, A. Dispenzieri, M. A. Gertz, T. E. Witzig, S. Kumar, S. R. Hayman, S. J. Russell, F. K. Buadi, S. M. Geyer, M. E. Campbell, R. A. Kyle, S. V. Rajkumar, P. R. Greipp, M. P. Kline, Y. Xiong, L. L. Moon-Tasson and K. A. Donovan (2009). 'Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.' Mayo Clin Proc 84(2): 114-122.
Luther, G. A., J. Lamplot, X. Chen, R. Rames, E. R. Wagner, X. Liu, A. Parekh, E. Huang, S. H. Kim, J. Shen, R. C. Haydon, T. C. He and H. H. Luu (2013). 'IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma.' Cancer Lett 336(1): 222-230.
Matsumura, Y. and H. N. Ananthaswamy (2004). 'Toxic effects of ultraviolet radiation on the skin.' Toxicol Appl Pharmacol 195(3): 298-308.
Mazumder, D. N., J. Das Gupta, A. Santra, A. Pal, A. Ghose and S. Sarkar (1998). 'Chronic arsenic toxicity in west Bengal--the worst calamity in the world.' J Indian Med Assoc 96(1): 4-7, 18.
Melkonian, S., M. Argos, B. L. Pierce, Y. Chen, T. Islam, A. Ahmed, E. H. Syed, F. Parvez, J. Graziano, P. J. Rathouz and H. Ahsan (2011). 'A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men.' Am J Epidemiol 173(2): 183-191.
Mueller, A. K., M. Labaied, S. H. Kappe and K. Matuschewski (2005). 'Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.' Nature 433(7022): 164-167.
Narayanan, D. L., R. N. Saladi and J. L. Fox (2010). 'Ultraviolet radiation and skin cancer.' Int J Dermatol 49(9): 978-986.
Okui, T. and Y. Fujiwara (1986). 'Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells.' Mutat Res 172(1): 69-76.
Qin, X. J., W. Liu, Y. N. Li, X. Sun, C. X. Hai, L. G. Hudson and K. J. Liu (2012). 'Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure.' Toxicol Sci 127(1): 120-129.
Qin, Y., S. Ekmekcioglu, P. Liu, L. M. Duncan, G. Lizee, N. Poindexter and E. A. Grimm (2011). 'Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma.' Mol Cancer Res 9(11): 1537-1550.
Raj, D., D. E. Brash and D. Grossman (2006). 'Keratinocyte apoptosis in epidermal development and disease.' J Invest Dermatol 126(2): 243-257.
Ratnaike, R. N. (2003). 'Acute and chronic arsenic toxicity.' Postgrad Med J 79(933): 391-396.
Reed, J. R., R. P. Leon, M. K. Hall and K. L. Schwertfeger (2009). 'Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.' Breast Cancer Res 11(2): R21.
Ristow, H. J. (1987). 'A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin 1 or a related protein.' Proc Natl Acad Sci U S A 84(7): 1940-1944.
Robbiani, D. F., R. A. Finch, D. Jager, W. A. Muller, A. C. Sartorelli and G. J. Randolph (2000). 'The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes.' Cell 103(5): 757-768.
Rossman, T. G. (2003). 'Mechanism of arsenic carcinogenesis: an integrated approach.' Mutat Res 533(1-2): 37-65.
Rossman, T. G., A. N. Uddin and F. J. Burns (2004). 'Evidence that arsenite acts as a cocarcinogen in skin cancer.' Toxicol Appl Pharmacol 198(3): 394-404.
Rossman, T. G., A. N. Uddin, F. J. Burns and M. C. Bosland (2001). 'Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis.' Toxicol Appl Pharmacol 176(1): 64-71.
Sauder, D. N., B. M. Stanulis-Praeger and B. A. Gilchrest (1988). 'Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging.' Arch Dermatol Res 280(2): 71-76.
Schafer, M. and S. Werner (2008). 'Cancer as an overhealing wound: an old hypothesis revisited.' Nat Rev Mol Cell Biol 9(8): 628-638.
Schroder, K. and J. Tschopp (2010). 'The inflammasomes.' Cell 140(6): 821-832.
Shi, H., L. G. Hudson and K. J. Liu (2004). 'Oxidative stress and apoptosis in metal ion-induced carcinogenesis.' Free Radic Biol Med 37(5): 582-593.
Snow, E. T. (1992). 'Metal carcinogenesis: mechanistic implications.' Pharmacol Ther 53(1): 31-65.
Spiewak, R. (2001). 'Pesticides as a cause of occupational skin diseases in farmers.' Ann Agric Environ Med 8(1): 1-5.
Sun, Y., C. Kojima, C. Chignell, R. Mason and M. P. Waalkes (2011). 'Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant response.' Toxicol Appl Pharmacol 255(3): 242-250.
Surdu, S., E. F. Fitzgerald, M. S. Bloom, F. P. Boscoe, D. O. Carpenter, R. F. Haase, E. Gurzau, P. Rudnai, K. Koppova, J. Fevotte, M. Vahter, G. Leonardi, W. Goessler, R. Kumar and T. Fletcher (2013). 'Occupational exposure to arsenic and risk of nonmelanoma skin cancer in a multinational European study.' Int J Cancer 133(9): 2182-2191.
Susse, S., C. J. Scholz, A. Burkle and L. Wiesmuller (2004). 'Poly(ADP-ribose) polymerase (PARP-1) and p53 independently function in regulating double-strand break repair in primate cells.' Nucleic Acids Res 32(2): 669-680.
Tu, S., G. Bhagat, G. Cui, S. Takaishi, E. A. Kurt-Jones, B. Rickman, K. S. Betz, M. Penz-Oesterreicher, O. Bjorkdahl, J. G. Fox and T. C. Wang (2008). 'Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.' Cancer Cell 14(5): 408-419.
Vega, L., M. Styblo, R. Patterson, W. Cullen, C. Wang and D. Germolec (2001). 'Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.' Toxicol Appl Pharmacol 172(3): 225-232.
Wang, S. Q., R. Setlow, M. Berwick, D. Polsky, A. A. Marghoob, A. W. Kopf and R. S. Bart (2001). 'Ultraviolet A and melanoma: a review.' J Am Acad Dermatol 44(5): 837-846.
Wang, X. P., M. Schunck, K. J. Kallen, C. Neumann, C. Trautwein, S. Rose-John and E. Proksch (2004). 'The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis.' J Invest Dermatol 123(1): 124-131.
Wanibuchi, H., T. Hori, V. Meenakshi, T. Ichihara, S. Yamamoto, Y. Yano, S. Otani, D. Nakae, Y. Konishi and S. Fukushima (1997). 'Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: association with elevated ornithine decarboxylase activity and formation of 8-hydroxydeoxyguanosine in the liver.' Jpn J Cancer Res 88(12): 1149-1154.
Wood, L. C., S. M. Jackson, P. M. Elias, C. Grunfeld and K. R. Feingold (1992). 'Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.' J Clin Invest 90(2): 482-487.
Wu, X., H. Liu, J. Liu, K. N. Haley, J. A. Treadway, J. P. Larson, N. Ge, F. Peale and M. P. Bruchez (2003). 'Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots.' Nat Biotechnol 21(1): 41-46.
Yamamoto, M. and S. Akira (2009). 'Lipid A receptor TLR4-mediated signaling pathways.' Adv Exp Med Biol 667: 59-68.
Zhou, R., A. S. Yazdi, P. Menu and J. Tschopp (2011). 'A role for mitochondria in NLRP3 inflammasome activation.' Nature 469(7329): 221-225.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/56368-
dc.description.abstract皮膚主要功能為隔離體內與外在環境,而皮膚障蔽主要是由最外層的角質層所構成。砷廣泛的存在於自然環境中,其主要影響的標的器官包括皮膚。砷又可分為有機砷及無機砷,文獻指出在所有的砷化合物以無機的三價砷最具毒性,因此過去實驗多以三價砷為探討對象。流行病學顯示長期經由飲水暴露砷,會導致皮膚色素沉著、過度角質化並增加罹患癌症之風險,包括皮膚癌、肝癌、肺癌以及膀胱癌。在砷誘導的癌症中,又以皮膚癌最為常見。在流行病學研究中顯示太陽光為另一促使皮膚癌生成之危險因子,尤其是紫外光中的中紫外線(Ultraviolet B, UVB)對於皮膚之致癌性最為顯著。砷與UVB皆會對人體皮膚具有致癌性,且兩者具有共致癌性。根據先前文獻指出在動物實驗中僅長期飲用含砷之水並不會導致皮膚癌生成,其必須要與UVB同時暴露才會增強皮膚致癌性。在一般情況下,砷的暴露途徑會經由食入,吸入或經皮暴露,但至今鮮少研究去探討職業上經皮暴露砷與皮膚癌之關聯性,然而近來有流行病學研究顯示在職業場所上經皮共同暴露砷與UVB會增加罹患皮膚癌之風險。本實驗目的是想要建立經皮接觸砷之方式來探討其與UVB之傷害,並釐清其共致癌性的相關機制。
實驗利用八週大雄性C57BL/6小鼠,在背皮照射100 mJ/cm2 UVB後立即塗抹上0.002% 三氧化二砷,在皮膚組織上發現共同暴露UVB和三氧化二砷顯著性的增加表皮厚度。而為了確定此現象是否是影響了角質細胞的增生與分化,實驗利用免疫螢光染色來確認具有增生功能的基底層(K5)和具有分化功能的上基底層(K10)之變化。結果顯示共同暴露UVB及三氧化二砷在48及72小時,K5和K10之表現顯著增加,這也代表著共同暴露UVB和三氧化二砷會刺激細胞增生並干擾細胞分化。除此之外,細胞增生標記Ki67和DNA損傷標記 gamma-H2Ax 表現之細胞數在共同暴露下48及72小時會協同性的增加。根據過去研究顯示表皮屏障功能被破壞,會誘發細胞激素的產生,因此接下來實驗利用細胞激素蛋白表達微陣列來探討在共同暴露UVB和三氧化二砷後表皮釋出細胞激素之變化。結果顯示UVB和三氧化二砷之暴露會參與IL-1R/TLR之訊息傳遞並影響IL-1beta的分泌。根據上述之結果,IL-1beta為此路徑之重要激素其會正向回饋結合至IL-1R,因此實驗接下來利用IL-1R1-/-小鼠來探討UVB和三氧化二砷協同性傷害是否是經由IL-1R之訊息傳遞所引起。結果顯示和野生型小鼠相比IL-1R-/-小鼠共同暴露UVB和三氧化二砷後,其表皮擁有正常的增生和分化,而Ki67和 gamma-H2Ax 表現之細胞數也顯著減少。綜合以上,本實驗建立了短期經皮接觸三氧化二砷之方式來探討與UVB之傷害之模式,並發現IL-1R之訊息傳遞在此傷害模式扮演著重要角色,而抑制此路徑可以降低UVB與三氧化二砷對表皮的協同性傷害。在未來會進一步探討此動物模式是否在長期下可誘導癌症之生成。
zh_TW
dc.description.abstractThe primary function of the skin is to protect the body from unwanted environmental influences. The main barrier of the skin is the outermost layer of the skin, the stratum corneum. Arsenic existed ubiquitously in the environment in both inorganic and organic forms, and skin is among the major target organs affected by arsenic exposure. The toxicity of trivalent arsenic is greater than other arsenic compounds. From epidemiologic studies, there is strong evidence that exposure to inorganic arsenic is associated with hyperpigmentation, hyperkeratosis in the skin and increased risk of carcinogenesis in various organs, including skin, lung, liver and urinary tract. Among these cancers, skin cancers are the most common. Epidemiologically, exposures to sunlight is shown to be the main cause of skin cancers. It has been shown that ultraviolet B (UVB) irradiation induces skin cancer in animals more effectively than other spectrum of sunlight. Arsenic and UVB, both as human skin carcinogens, may act together as co-carcinogens. Interestingly, arsenic alone does not seem sufficient to induce skin cancer in animals. In mouse skin, it appears that arsenic acts as a co-carcinogen by enhancing UV irradiation-induced skin cancer when it is simultaneously added to drinking water. In general, the primary routes of arsenic entry into the body are via ingestion, inhalation and skin exposure. Up to date, there are few studies examining potential links between arsenic skin exposure at work and skin carcinogenesis. However, recent epidemiological studies showed that workplace coexposure to arsenic and sunlight may increase the risk of skin cancer. This study is aimed at establishing an animal model to investigate the effect of coexposure of skin to arsenic and UVB and to examine the potential Imechenisms of the co-carcinogenicity of UVB and arsenic.
The 8week-old male C57BL/6 mice were used for this in vivo model, and 0.002% arsenic trioxide (As2O3, As) was applied immediately onto the skin after exposure to 100 mJ/cm2 UVB. Histopathologically, the epidermis exhibited a dramatic increase in thickness at 48h and 72h following co-exposure to arsenic trioxide and UVB. To evaluate the effects of UVB and arsenic trioxide on the proliferation and differentiation of epidermal keratinocytes, immunofluorescence staining was performed. Histological images of immunofluorescence staining revealed expansion of the proliferating basal layer (K5) and suprabasal layer (K10) after co-exposure to arsenic and UVB at 48h and 72h. This shows that co-exposure to arsenic and UVB may stimulate cell proliferation of the basal layer and disturb the differentiation. In addition, the number of Ki67 and gamma-H2Ax positive cells was also increased at 48h and 72h According to previous studies, epidermal barrier perturbation can induce a cytokine cascade. In this study, a cytokine antibody array was used to evaluate the profiles of the epidermal cytokines released following UVB and arsenic trioxide co-exposure. We revealed increased IL-1beta secretion. We then used mice that were deficient in IL-1R to assess the contribution of IL-1R signaling to the pathological changes. Compared to wild-type mice, IL-1R deficient mice exhibited normal epidermal histology and their Ki67 and gamma-H2Ax cell numbers were significantly reduced.In summary, our study provides a short-term animal model that illustrates the effect of co-exposure to arsenic trioxide and UVB and reveals an important role of IL-1R signaling in the associated pathological changes. The synergistic damage to the epidermis caused by co-exposure to arsenic trioxide and UVB can be reduced by inhibiting IL-1R signaling. In the future, we will examine the potential carcinogenic effect of long-term co-exposure to arsenic trioxide and UVB.
en
dc.description.provenanceMade available in DSpace on 2021-06-16T05:25:24Z (GMT). No. of bitstreams: 1
ntu-103-R01447009-1.pdf: 5216972 bytes, checksum: 985c767a260b1658d880348dae8a43e7 (MD5)
Previous issue date: 2014
en
dc.description.tableofcontents誌謝 i
中文摘要 ii-iii
英文摘要 iv-v
目錄 vi-xiii
圖目錄 ix-x
縮寫表 xi
第一章 緒論 1
1.1 皮膚障蔽 2
1.2 砷 3
1. 3 砷與皮膚癌之關聯 4
1. 4 太陽光紫外線 5
1. 5 UVB與皮膚癌之關聯 6
1. 6 砷與UVB 7
1. 7 研究動機 8
第二章 實驗材料與方法 9
2.1 實驗材料 10
2.1.1 細胞株 10
2.1.2 動物 10
2.2 藥品與試劑 10
2.1.1 細胞培養 10
2.1.2 cDNA之製備以及聚合酶鏈鎖反應 11
2.1.3 免疫螢光染色 11
2. 3 實驗方法 11
2. 3.1 細胞株之培養 11
2. 3.2 細胞毒性測試 12
2. 3.3. 動物實驗設計 12
2. 3.4 皮膚組織石蠟包埋 13
2. 3.5 蘇木紫-伊紅染色 13
2. 3.6 雙重免疫螢光染色 14
2. 3.7 疫螢光染色 14
2. 3.8 TUNEL assay 15
2. 3.9 小鼠角質細胞之分離 15
2. 3.10 細胞激素蛋白表達微陣列 16
2. 3.11 核醣核酸之萃取與cDNA之製備16
2. 3.12 即時聚合酶連鎖反應 17
2. 3.13 統計與分析 17
第三章 實驗結果 18
3.1 共同暴露UVB和三氧化二砷協同性的降低人類角質細胞存活率 19
3.2 建立短期經皮接觸三氧化二砷與UVB之傷害之模式 19
3.3 暴露UVB及三氧化二砷,促使小鼠皮膚部分紅斑及紅腫 20
3.4 共同暴露UVB及三氧化二砷,促使小鼠表皮顯著增厚 20
3.5 共同暴露UVB及三氧化二砷增加表皮細胞分裂並干擾細胞分化 20-21
3.6 共同處理UVB及三氧化二砷顯著增加增殖標記之細胞 21
3.7 處理UVB及三氧化二砷不會誘導表皮細胞走向凋亡機制 22
3.8 共同處理UVB及三氧化二砷促使表皮細胞之DNA損傷 22-23
3.9 共同暴露UVB及三氧化二砷參與IL-1R及TLR訊息傳遞路徑 23-24
3.10 暴露UVB和三氧化二砷促使IL-1R訊息傳遞路徑分泌IL-1β 24-25
3.11 利用IL-1R-/-小鼠抑制IL-1R訊息傳遞路徑 25
3.12 IL-1R-/-小鼠可降低共同暴露UVB及三氧化二砷所造成之傷害 25-26
第四章 討論 27
4.1 經皮暴露三氧化二砷增加UVB之致癌風險 28-29
4.2 IL-1β干擾細胞增生及分化 29
4.3 NLRP3發炎體參與IL-1R訊息傳遞 29-30
第五章 結論與未來方向 31-32
圖表集 33-68
參考文獻 69-83
dc.language.isozh-TW
dc.subject砷zh_TW
dc.subject紫外光zh_TW
dc.subject角質細胞zh_TW
dc.subject增生zh_TW
dc.subject分化zh_TW
dc.subjectUVBen
dc.subjectdifferentiationen
dc.subjectproliferationen
dc.subjectkeratinocyteen
dc.subjectarsenicen
dc.title暴露三氧化二砷及UVB干擾角質細胞增生和分化之機制探討zh_TW
dc.titleThe Mechanisms of Disturbed Keratinocyte Proliferation and Differentiation Induced by Arsenic Trioxide Exposure after UVB Injuryen
dc.typeThesis
dc.date.schoolyear102-2
dc.description.degree碩士
dc.contributor.oralexamcommittee李志宏(Chih-Hung Lee)
dc.subject.keyword砷,紫外光,角質細胞,增生,分化,zh_TW
dc.subject.keywordarsenic,UVB,keratinocyte,proliferation,differentiation,en
dc.relation.page83
dc.rights.note有償授權
dc.date.accepted2014-08-15
dc.contributor.author-college醫學院zh_TW
dc.contributor.author-dept毒理學研究所zh_TW
顯示於系所單位:毒理學研究所

文件中的檔案:
檔案 大小格式 
ntu-103-1.pdf
  未授權公開取用
5.09 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved